IBDEI0B0 ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11011,2)
 ;;=^5002122
 ;;^UTILITY(U,$J,358.3,11012,0)
 ;;=D31.31^^53^606^17
 ;;^UTILITY(U,$J,358.3,11012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11012,1,3,0)
 ;;=3^Choroidal Nevus,Right Eye
 ;;^UTILITY(U,$J,358.3,11012,1,4,0)
 ;;=4^D31.31
 ;;^UTILITY(U,$J,358.3,11012,2)
 ;;=^5002121
 ;;^UTILITY(U,$J,358.3,11013,0)
 ;;=H34.813^^53^606^13
 ;;^UTILITY(U,$J,358.3,11013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11013,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Bilateral
 ;;^UTILITY(U,$J,358.3,11013,1,4,0)
 ;;=4^H34.813
 ;;^UTILITY(U,$J,358.3,11013,2)
 ;;=^5005570
 ;;^UTILITY(U,$J,358.3,11014,0)
 ;;=H34.812^^53^606^14
 ;;^UTILITY(U,$J,358.3,11014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11014,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,11014,1,4,0)
 ;;=4^H34.812
 ;;^UTILITY(U,$J,358.3,11014,2)
 ;;=^5005569
 ;;^UTILITY(U,$J,358.3,11015,0)
 ;;=H34.811^^53^606^15
 ;;^UTILITY(U,$J,358.3,11015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11015,1,3,0)
 ;;=3^Central Retinal Vein Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,11015,1,4,0)
 ;;=4^H34.811
 ;;^UTILITY(U,$J,358.3,11015,2)
 ;;=^5005568
 ;;^UTILITY(U,$J,358.3,11016,0)
 ;;=E11.321^^53^606^66
 ;;^UTILITY(U,$J,358.3,11016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11016,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,11016,1,4,0)
 ;;=4^E11.321
 ;;^UTILITY(U,$J,358.3,11016,2)
 ;;=^5002634
 ;;^UTILITY(U,$J,358.3,11017,0)
 ;;=E11.329^^53^606^67
 ;;^UTILITY(U,$J,358.3,11017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11017,1,3,0)
 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,11017,1,4,0)
 ;;=4^E11.329
 ;;^UTILITY(U,$J,358.3,11017,2)
 ;;=^5002635
 ;;^UTILITY(U,$J,358.3,11018,0)
 ;;=E11.331^^53^606^68
 ;;^UTILITY(U,$J,358.3,11018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11018,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,11018,1,4,0)
 ;;=4^E11.331
 ;;^UTILITY(U,$J,358.3,11018,2)
 ;;=^5002636
 ;;^UTILITY(U,$J,358.3,11019,0)
 ;;=E11.339^^53^606^69
 ;;^UTILITY(U,$J,358.3,11019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11019,1,3,0)
 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,11019,1,4,0)
 ;;=4^E11.339
 ;;^UTILITY(U,$J,358.3,11019,2)
 ;;=^5002637
 ;;^UTILITY(U,$J,358.3,11020,0)
 ;;=E11.351^^53^606^70
 ;;^UTILITY(U,$J,358.3,11020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11020,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,11020,1,4,0)
 ;;=4^E11.351
 ;;^UTILITY(U,$J,358.3,11020,2)
 ;;=^5002640
 ;;^UTILITY(U,$J,358.3,11021,0)
 ;;=E11.359^^53^606^71
 ;;^UTILITY(U,$J,358.3,11021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11021,1,3,0)
 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,11021,1,4,0)
 ;;=4^E11.359
 ;;^UTILITY(U,$J,358.3,11021,2)
 ;;=^5002641
 ;;^UTILITY(U,$J,358.3,11022,0)
 ;;=E11.341^^53^606^72
 ;;^UTILITY(U,$J,358.3,11022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11022,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,11022,1,4,0)
 ;;=4^E11.341
 ;;^UTILITY(U,$J,358.3,11022,2)
 ;;=^5002638
 ;;^UTILITY(U,$J,358.3,11023,0)
 ;;=E11.349^^53^606^73
 ;;^UTILITY(U,$J,358.3,11023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11023,1,3,0)
 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,11023,1,4,0)
 ;;=4^E11.349
 ;;^UTILITY(U,$J,358.3,11023,2)
 ;;=^5002639
 ;;^UTILITY(U,$J,358.3,11024,0)
 ;;=E11.9^^53^606^74
 ;;^UTILITY(U,$J,358.3,11024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11024,1,3,0)
 ;;=3^Type 2 DM w/o Complications
 ;;^UTILITY(U,$J,358.3,11024,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,11024,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,11025,0)
 ;;=H35.363^^53^606^18
 ;;^UTILITY(U,$J,358.3,11025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11025,1,3,0)
 ;;=3^Drusen of Macular,Bilateral
 ;;^UTILITY(U,$J,358.3,11025,1,4,0)
 ;;=4^H35.363
 ;;^UTILITY(U,$J,358.3,11025,2)
 ;;=^5005660
 ;;^UTILITY(U,$J,358.3,11026,0)
 ;;=H35.362^^53^606^19
 ;;^UTILITY(U,$J,358.3,11026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11026,1,3,0)
 ;;=3^Drusen of Macular,Left Eye
 ;;^UTILITY(U,$J,358.3,11026,1,4,0)
 ;;=4^H35.362
 ;;^UTILITY(U,$J,358.3,11026,2)
 ;;=^5005659
 ;;^UTILITY(U,$J,358.3,11027,0)
 ;;=H35.361^^53^606^20
 ;;^UTILITY(U,$J,358.3,11027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11027,1,3,0)
 ;;=3^Drusen of Macular,Right Eye
 ;;^UTILITY(U,$J,358.3,11027,1,4,0)
 ;;=4^H35.361
 ;;^UTILITY(U,$J,358.3,11027,2)
 ;;=^5005658
 ;;^UTILITY(U,$J,358.3,11028,0)
 ;;=H04.123^^53^606^21
 ;;^UTILITY(U,$J,358.3,11028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11028,1,3,0)
 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
 ;;^UTILITY(U,$J,358.3,11028,1,4,0)
 ;;=4^H04.123
 ;;^UTILITY(U,$J,358.3,11028,2)
 ;;=^5004465
 ;;^UTILITY(U,$J,358.3,11029,0)
 ;;=H35.32^^53^606^28
 ;;^UTILITY(U,$J,358.3,11029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11029,1,3,0)
 ;;=3^Exudative Age-Related Macular Degeneration
 ;;^UTILITY(U,$J,358.3,11029,1,4,0)
 ;;=4^H35.32
 ;;^UTILITY(U,$J,358.3,11029,2)
 ;;=^5005648
 ;;^UTILITY(U,$J,358.3,11030,0)
 ;;=H35.023^^53^606^29
 ;;^UTILITY(U,$J,358.3,11030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11030,1,3,0)
 ;;=3^Exudative Retinopathy,Bilateral
 ;;^UTILITY(U,$J,358.3,11030,1,4,0)
 ;;=4^H35.023
 ;;^UTILITY(U,$J,358.3,11030,2)
 ;;=^5005588
 ;;^UTILITY(U,$J,358.3,11031,0)
 ;;=H35.022^^53^606^30
 ;;^UTILITY(U,$J,358.3,11031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11031,1,3,0)
 ;;=3^Exudative Retinopathy,Left Eye
 ;;^UTILITY(U,$J,358.3,11031,1,4,0)
 ;;=4^H35.022
 ;;^UTILITY(U,$J,358.3,11031,2)
 ;;=^5005587
 ;;^UTILITY(U,$J,358.3,11032,0)
 ;;=H35.021^^53^606^31
 ;;^UTILITY(U,$J,358.3,11032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11032,1,3,0)
 ;;=3^Exudative Retinopathy,Right Eye
 ;;^UTILITY(U,$J,358.3,11032,1,4,0)
 ;;=4^H35.021
 ;;^UTILITY(U,$J,358.3,11032,2)
 ;;=^5005586
 ;;^UTILITY(U,$J,358.3,11033,0)
 ;;=H40.013^^53^606^32
 ;;^UTILITY(U,$J,358.3,11033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11033,1,3,0)
 ;;=3^Glaucoma Suspect,Open Angle w/ Borderline Findings,Low Risk,Bilateral
 ;;^UTILITY(U,$J,358.3,11033,1,4,0)
 ;;=4^H40.013
 ;;^UTILITY(U,$J,358.3,11033,2)
 ;;=^5005726
 ;;^UTILITY(U,$J,358.3,11034,0)
 ;;=H40.012^^53^606^33
 ;;^UTILITY(U,$J,358.3,11034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11034,1,3,0)
 ;;=3^Glaucoma Suspect,Open Angle w/ Borderline Findings,Low Risk,Left Eye
 ;;^UTILITY(U,$J,358.3,11034,1,4,0)
 ;;=4^H40.012
 ;;^UTILITY(U,$J,358.3,11034,2)
 ;;=^5005725
 ;;^UTILITY(U,$J,358.3,11035,0)
 ;;=H40.011^^53^606^34
 ;;^UTILITY(U,$J,358.3,11035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11035,1,3,0)
 ;;=3^Glaucoma Suspect,Open Angle w/ Borderline Findings,Low Risk,Right Eye
 ;;^UTILITY(U,$J,358.3,11035,1,4,0)
 ;;=4^H40.011
 ;;^UTILITY(U,$J,358.3,11035,2)
 ;;=^5005724
 ;;^UTILITY(U,$J,358.3,11036,0)
 ;;=H52.03^^53^606^41
 ;;^UTILITY(U,$J,358.3,11036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11036,1,3,0)
 ;;=3^Hypermetropia,Bilateral
 ;;^UTILITY(U,$J,358.3,11036,1,4,0)
 ;;=4^H52.03
 ;;^UTILITY(U,$J,358.3,11036,2)
 ;;=^5006262
 ;;^UTILITY(U,$J,358.3,11037,0)
 ;;=H52.02^^53^606^42
 ;;^UTILITY(U,$J,358.3,11037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11037,1,3,0)
 ;;=3^Hypermetropia,Left Eye
 ;;^UTILITY(U,$J,358.3,11037,1,4,0)
 ;;=4^H52.02
 ;;^UTILITY(U,$J,358.3,11037,2)
 ;;=^5006261
 ;;^UTILITY(U,$J,358.3,11038,0)
 ;;=H52.01^^53^606^43
 ;;^UTILITY(U,$J,358.3,11038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11038,1,3,0)
 ;;=3^Hypermetropia,Right Eye
